Vor Biopharma (VOR) Current Leases (2020 - 2026)
Vor Biopharma (VOR) reported Current Leases of $307000.0 for Q1 2026, down 92.8% year-over-year from $4.3 million in Q1 2025, and up 9.64% on a QoQ basis from $280000.0 in Q4 2025.
Vor Biopharma (VOR) has 7 years of Current Leases data on file, last reported at $307000.0 in Q1 2026.
- Quarterly Current Leases fell 92.8% year-over-year to $307000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $307000.0 (down 92.8% YoY) and the FY2025 annual result came in at $280000.0, down 93.36% from the prior year.
- Current Leases rose to $307000.0 in Q1 2026 per VOR's latest filing, from $280000.0 in the prior quarter.
- Across five years, Current Leases topped out at $7.3 million in Q1 2022 and bottomed at $252000.0 in Q3 2025.
- The 5-year median for Current Leases is $3.8 million (2022), against an average of $3.5 million.
- The widest annual swing landed in 2022, when Current Leases soared 530.39%; it then plunged 93.95% in 2025.
- Tracing VOR's Current Leases over 5 years: stood at $3.3 million in 2022, then gained by 17.05% to $3.8 million in 2023, then climbed by 10.05% to $4.2 million in 2024, then sank by 93.36% to $280000.0 in 2025, then gained by 9.64% to $307000.0 in 2026.
- Per Business Quant, the three latest VOR Current Leases figures stand at $307000.0 (Q1 2026), $280000.0 (Q4 2025), and $252000.0 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 83,991.00 |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 7.40 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 720.00 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 45.66 Mn |
| 10 | Vor Biopharma | 628.83 Mn | 628.83 Mn | - | 307,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 307,000.00 |
| Dec 31, 2025 | 280,000.00 |
| Sep 30, 2025 | 252,000.00 |
| Mar 31, 2025 | 4.27 Mn |
| Dec 31, 2024 | 4.22 Mn |
| Sep 30, 2024 | 4.16 Mn |
| Jun 30, 2024 | 4.11 Mn |
| Mar 31, 2024 | 3.96 Mn |
| Dec 31, 2023 | 3.83 Mn |
| Sep 30, 2023 | 3.74 Mn |
| Jun 30, 2023 | 3.69 Mn |
| Mar 31, 2023 | 3.71 Mn |
| Dec 31, 2022 | 3.27 Mn |
| Sep 30, 2022 | 3.76 Mn |
| Jun 30, 2022 | 4.43 Mn |
| Mar 31, 2022 | 7.28 Mn |
| Dec 31, 2021 | 1.84 Mn |
| Sep 30, 2021 | 1.15 Mn |
| Jun 30, 2021 | 1.16 Mn |
| Mar 31, 2021 | 1.16 Mn |
| Dec 31, 2020 | 863,000.00 |